(Q69606630)
Statements
Verapamil reversal of clinical doxorubicin resistance in human cancer. A Wilshire Oncology Medical Group pilot phase I-II study (English)
C A Presant
P S Kennedy
C Wiseman
K Gala
A Bouzaglou
M Wyres
1 August 1986